| SC 13D | 2022-12-15 | Salomonsky Henry Louis | Immune Therapeutics, Inc. | 12,168,900 | 14.7% | EDGAR |
| SC 13D | 2021-06-07 | Griffin Noreen | Immune Therapeutics, Inc. | 59,877 | 12.4% | EDGAR |
| SC 13G/A | 2020-06-26 | Ahmetaj Erjon | Immune Therapeutics, Inc. | 22,349 | 4.9% | EDGAR |
| SC 13G/A | 2020-05-19 | Iliad Research & Trading, L.P. | Immune Therapeutics, Inc. | 45,712 | 10.0% | EDGAR |
| SC 13G | 2019-12-10 | Ahmetaj Erjon | Immune Therapeutics, Inc. | 22,349 | 5.0% | EDGAR |
| SC 13G/A | 2019-05-16 | Iliad Research & Trading, L.P. | Immune Therapeutics, Inc. | 45,512,222 | 10.0% | EDGAR |
| SC 13G | 2018-05-15 | Iliad Research & Trading, L.P. | Immune Therapeutics, Inc. | 38,945,626 | 10.0% | EDGAR |
| SC 13G/A | 2015-06-02 | DAILEY ROBERT JACKMAN | Immune Therapeutics, Inc. | 10,497,262 | 7.0% | EDGAR |
| SC 13G | 2014-12-10 | DAILEY ROBERT JACKMAN | Immune Therapeutics, Inc. | 9,334,942 | 7.0% | EDGAR |